{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:25:35Z","timestamp":1769063135590,"version":"3.49.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Thiazide diuretics are commonly prescribed for the treatment of hypertension, a disease highly prevalent among older individuals and in those with chronic kidney disease. How specific thiazide diuretics compare in regard to safety and clinical outcomes in these populations remains unknown.<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare safety and clinical outcomes associated with chlorthalidone or hydrochlorothiazide use among older adults with varying levels of kidney function.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This population-based retrospective cohort study was conducted in Ontario, Canada, from 2007 to 2015. Participants included adults aged 66 years or older who initiated chlorthalidone or hydrochlorothiazide during this period. Data were analyzed from December 2019 through September 2020.<\/jats:p><\/jats:sec>Exposures<\/jats:title>New chlorthalidone users were matched 1:4 with new hydrochlorothiazide users by a high-dimensional propensity score. Time-to-event models accounting for competing risks examined the associations between chlorthalidone vs hydrochlorothiazide use and the outcomes of interest overall and within estimated glomerular filtration rate (eGFR) categories (\u226560, 45-59, and &amp;lt;45 mL\/min\/1.73 m2<\/jats:sup>).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The outcomes of interest were adverse kidney events (ie, eGFR decline \u226530%, dialysis, or kidney transplantation), cardiovascular events (composite of myocardial infarction, coronary revascularization, heart failure, or atrial fibrillation), all-cause mortality, and electrolyte anomalies (ie, sodium or potassium levels outside reference ranges).<\/jats:p><\/jats:sec>Results<\/jats:title>After propensity score matching, the study cohort included 12\u202f722 adults (mean [SD] age, 74 [7] years; 7063 [56%] women; 5659 [44%] men; mean [SD] eGFR, 69 [19] mL\/min\/1.73 m2<\/jats:sup>), including 2936 who received chlorthalidone and 9786 who received hydrochlorothiazide. Chlorthalidone use was associated with a higher risk of eGFR decline of 30% or greater (hazard ratio [HR], 1.24 [95% CI, 1.13-1.36]) and cardiovascular events (HR, 1.12 [95% CI, 1.04-1.22]) across all eGFR categories compared with hydrochlorothiazide use. Chlorthalidone use was also associated with a higher risk of hypokalemia compared with hydrochlorothiazide use, which was more pronounced among those with higher eGFR (eGFR \u226560 mL\/min\/1.73 m2<\/jats:sup>: HR, 1.86 [95% CI, 1.67-2.08]; eGFR 45-59 mL\/min\/1.73 m2<\/jats:sup>: HR, 1.57 [95% CI, 1.25-1.96]; eGFR &amp;lt;45 mL\/min\/1.73 m2<\/jats:sup>: HR, 1.10 [95% CI, 0.84-1.45]; P<\/jats:italic> for interaction\u2009=\u2009.001). No significant differences were observed between chlorthalidone and hydrochlorothiazide for dialysis or kidney transplantation (HR, 1.44 [95% CI, 0.88-2.36]), all-cause mortality (HR, 1.10 [95% CI, 0.93-1.29]), hyperkalemia (HR, 1.05 [95% CI, 0.79-1.39]), or hyponatremia (HR, 1.14 [95% CI, CI 0.98-1.32]).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This cohort study found that among older adults, chlorthalidone use was associated with a higher risk of eGFR decline, cardiovascular events, and hypokalemia compared with hydrochlorothiazide use. The excess risk of hypokalemia with chlorthalidone was attenuated in participants with reduced kidney function. Placed in context with prior observational studies comparing the safety and clinical outcomes associated with thiazide diuretics, these results suggest that there is no evidence to prefer chlorthalidone over hydrochlorothiazide.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2021.23365","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T15:16:18Z","timestamp":1631718978000},"page":"e2123365","source":"Crossref","is-referenced-by-count":28,"title":["Comparison of Clinical Outcomes and Safety Associated With Chlorthalidone vs Hydrochlorothiazide in Older Adults With Varying Levels of Kidney Function"],"prefix":"10.1001","volume":"4","author":[{"given":"Cedric","family":"Edwards","sequence":"first","affiliation":[{"name":"Ottawa Hospital Research Institute, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory L.","family":"Hundemer","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Petrcich","sequence":"additional","affiliation":[{"name":"Institute for Clinical Evaluative Sciences, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Canney","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Knoll","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Burns","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Bugeja","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish M.","family":"Sood","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada"},{"name":"Institute for Clinical Evaluative Sciences, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"issue":"9995","key":"zoi210683r1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","article-title":"Hypertension.","volume":"386","author":"Poulter","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"zoi210683r2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association.","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"7653","key":"zoi210683r3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.","volume":"336","author":"Turnbull","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"zoi210683r4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"zoi210683r5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children.","volume":"36","author":"Rabi","year":"2020","journal-title":"Can J Cardiol"},{"issue":"33","key":"zoi210683r6","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension.","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"zoi210683r7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/jch.2010.12.issue-12","article-title":"Renewed interest in chlorthalidone: evidence from the Veterans Health Administration.","volume":"12","author":"Ernst","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"zoi210683r8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy.","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi210683r9","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1073\/pnas.85.7.2311","article-title":"Thiazide diuretic drug receptors in rat kidney: identification with [3H]metolazone.","volume":"85","author":"Beaumont","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"zoi210683r10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","article-title":"Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.","volume":"43","author":"Carter","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"zoi210683r11","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.111.190637","article-title":"Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.","volume":"59","author":"Peterzan","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"zoi210683r12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/HYPERTENSIONAHA.110.161505","article-title":"Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.","volume":"57","author":"Dorsch","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"zoi210683r13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","article-title":"Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.","volume":"47","author":"Ernst","year":"2006","journal-title":"Hypertension"},{"issue":"9","key":"zoi210683r14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jch.2012.14.issue-9","article-title":"The comparative effectiveness of hydrochlorothiazide and chlorthalidone in an observational cohort of veterans.","volume":"14","author":"Lund","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"zoi210683r15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7326\/0003-4819-158-6-201303190-00004","article-title":"Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study.","volume":"158","author":"Dhalla","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi210683r16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jamainternmed.2019.7454","article-title":"Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension.","volume":"180","author":"Hripcsak","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi210683r17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) study.","volume":"55","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"zoi210683r18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/01.CIR.23.2.200","article-title":"Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics.","volume":"23","author":"Reubi","year":"1961","journal-title":"Circulation"},{"issue":"4","key":"zoi210683r19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/nyas.1958.71.issue-4","article-title":"Chlorothiazide in renal disease.","volume":"71","author":"Schreiner","year":"1958","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"zoi210683r20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1681\/ASN.2019090905","article-title":"A randomized trial of distal diuretics versus dietary sodium restriction for hypertension in chronic kidney disease.","volume":"31","author":"Bov\u00e9e","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"zoi210683r21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.113.02793","article-title":"Parallel-group 8-week study on chlorthalidone effects in hypertensives with low kidney function.","volume":"63","author":"Cirillo","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"zoi210683r22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ndt\/gfh650","article-title":"A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.","volume":"20","author":"Dussol","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"zoi210683r23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000358603","article-title":"Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study.","volume":"39","author":"Agarwal","year":"2014","journal-title":"Am J Nephrol"},{"issue":"5","key":"zoi210683r24","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2215\/CJN.04330418","article-title":"Clinical pharmacology of antihypertensive therapy for the treatment of hypertension in CKD.","volume":"14","author":"Sinha","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"zoi210683r26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi210683r27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"6","key":"zoi210683r28","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"12","key":"zoi210683r29","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/pds.v17:12","article-title":"Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score.","volume":"17","author":"Austin","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"zoi210683r30","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","article-title":"Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses.","volume":"59","author":"Roush","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"zoi210683r31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.105.542290","article-title":"Antihypertensive medication use among US adults with hypertension.","volume":"113","author":"Gu","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"zoi210683r32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/M16-1208","article-title":"Chlorthalidone versus hydrochlorothiazide: a new kind of veterans affairs cooperative study.","volume":"165","author":"Lederle","year":"2016","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi210683r33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/00004872-200107000-00018","article-title":"High and low serum potassium associated with cardiovascular events in diuretic-treated patients.","volume":"19","author":"Cohen","year":"2001","journal-title":"J Hypertens"},{"issue":"5","key":"zoi210683r34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/01.HYP.35.5.1025","article-title":"Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.","volume":"35","author":"Franse","year":"2000","journal-title":"Hypertension"},{"issue":"8","key":"zoi210683r35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archinte.161.8.1089","article-title":"Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases.","volume":"161","author":"Paltiel","year":"2001","journal-title":"Arch Intern Med"},{"issue":"26","key":"zoi210683r36","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest.","volume":"330","author":"Siscovick","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi210683r37","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/jamia\/ocaa103","article-title":"Principles of Large-scale Evidence Generation and Evaluation Across a Network of Databases (LEGEND).","volume":"27","author":"Schuemie","year":"2020","journal-title":"J Am Med Inform Assoc"},{"issue":"10","key":"zoi210683r38","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jamainternmed.2019.1455","article-title":"Use of directly observed therapy to assess treatment adherence in patients with apparent treatment-resistant hypertension.","volume":"179","author":"Ruzicka","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"4","key":"zoi210683r39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.119.14360","article-title":"Trends in antihypertensive medication monotherapy and combination use among US Adults, National Health and Nutrition Examination Survey 2005-2016.","volume":"75","author":"Derington","year":"2020","journal-title":"Hypertension"},{"key":"zoi210683r25","unstructured":"Statistics Canada. Population estimates on July 1st, by age and sex. Accessed April 19, 2021. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784119\/edwards_2021_oi_210683_1683909337.51445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T15:00:54Z","timestamp":1684767654000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.23365","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]}}}